Search

Author/Creator Banerjee, Poulabi

1. Effect of alirocumab on specific lipoprotein non-high-density lipoprotein cholesterol and subfractions as measured by the vertical auto profile method: analysis of 3 randomized trials versus placebo. Issue 1 (December 2016)

Authors:
Toth, Peter; Hamon, Sara; Jones, Steven; Martin, Seth; Joshi, Parag; Kulkarni, Krishnaji; Banerjee, Poulabi; Hanotin, Corinne; Roth, Eli; McKenney, James
Journal:
Lipids in health and disease
Issue:
Volume 15:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Effect of PCSK9 Inhibition by Alirocumab on Lipoprotein Particle Concentrations Determined by Nuclear Magnetic Resonance Spectroscopy. Issue 11 (19th November 2015)

Authors:
Koren, Michael J.; Kereiakes, Dean; Pourfarzib, Ray; Winegar, Deborah; Banerjee, Poulabi; Hamon, Sara; Hanotin, Corinne; McKenney, James M.
Journal:
Journal of the American Heart Association
Issue:
Volume 4:Issue 11(2015)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Effect of PCSK9 Inhibition by Alirocumab on Lipoprotein Particle Concentrations Determined by Nuclear Magnetic Resonance Spectroscopy. Issue 11 (November 2015)

Authors:
Koren, Michael J.; Kereiakes, Dean; Pourfarzib, Ray; Winegar, Deborah; Banerjee, Poulabi; Hamon, Sara; Hanotin, Corinne; McKenney, James M.
Journal:
Journal of the American Heart Association
Issue:
Volume 4:Issue 11(2015)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Functional Analysis of LDLR (Low-Density Lipoprotein Receptor) Variants in Patient Lymphocytes to Assess the Effect of Evinacumab in Homozygous Familial Hypercholesterolemia Patients With a Spectrum of LDLR Activity. Issue 11 (November 2019)

Authors:
Banerjee, Poulabi; Chan, Kuo-Chen; Tarabocchia, Michel; Benito-Vicente, Asier; Alves, Ana C.; Uribe, Kepa B.; Bourbon, Mafalda; Skiba, Paul J.; Pordy, Robert; Gipe, Daniel A.; Gaudet, Daniel; Martin, Cesar
Journal:
Arteriosclerosis, thrombosis, and vascular biology
Issue:
Volume 39:Issue 11(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia. Issue 6 (6th August 2019)

Authors:
Ahmad, Zahid; Banerjee, Poulabi; Hamon, Sara; Chan, Kuo-Chen; Bouzelmat, Aurelie; Sasiela, William J.; Pordy, Robert; Mellis, Scott; Dansky, Hayes; Gipe, Daniel A.; Dunbar, Richard L.
Journal:
Circulation
Issue:
Volume 140:Issue 6(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial. Issue 8 (25th February 2020)

Authors:
Damask, Amy; Steg, P. Gabriel; Schwartz, Gregory G.; Szarek, Michael; Hagström, Emil; Badimon, Lina; Chapman, M. John; Boileau, Catherine; Tsimikas, Sotirios; Ginsberg, Henry N.; Banerjee, Poulabi; Manvelian, Garen; Pordy, Robert; Hess, Sibylle; Overton, John D.; Lotta, Luca A.; Yancopoulos, Geor...
Journal:
Circulation
Issue:
Volume 141:Issue 8(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Pharmacogenomic Study of Statin-Associated Muscle Symptoms in the ODYSSEY OUTCOMES Trial. (11th May 2022)

Authors:
Murphy, William A.; Lin, Nan; Damask, Amy; Schwartz, Gregory G.; Steg, P. Gabriel; Szarek, Michael; Banerjee, Poulabi; Fazio, Sergio; Manvelian, Garen; Pordy, Robert; Shuldiner, Alan R.; Paulding, Charles
Journal:
Circulation
Issue:
Volume 15:Number 3(2022)
Page Start:
e003503
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗